^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Diffuse Large B Cell Lymphoma |
| Drug: | Adcetris (brentuximab vedotin) (Microtubule inhibitor, CD30-targeted antibody-drug conjugate) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Diffuse Large B-cell Lymphoma…Useful in certain circumstances...Brentuximab vedotin for CD30+ disease...
